Back to Search
Start Over
Direct vasoconstrictor effect of prostaglandin E2 on renal interlobular arteries: role of the EP3 receptor.
- Source :
-
American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2007 Mar; Vol. 292 (3), pp. F1094-101. Date of Electronic Publication: 2006 Dec 05. - Publication Year :
- 2007
-
Abstract
- Evidence indicates that prostaglandin E(2) (PGE(2)) preferentially affects preglomerular renal vessels. However, whether this is limited to small-caliber arterioles or whether larger vessels farther upstream also respond to PGE(2) is currently unclear. In the present study, we first investigated the effects of PGE(2) along the preglomerular vascular tree and subsequently focused on proximal interlobular arteries (ILAs). Proximal ILAs in hydronephrotic rat kidneys as well as isolated vessels from normal kidneys constricted in response to PGE(2), both under basal conditions and after the induction of vascular tone. By contrast, smaller vessels, i.e., distal ILAs and afferent arterioles, exhibited PGE(2)-induced vasodilation. Endothelium removal and pretreatment of single, isolated proximal ILAs with an EP1 receptor blocker (SC51322, 1 micromol/l) or a thromboxane A(2) receptor blocker (SQ29548, 1 micromol/l) did not prevent vasoconstriction to PGE(2). Furthermore, in the presence of SC51322, responses of these vessels to PGE(2) and the EP1/EP3 agonist sulprostone were superimposable, indicating that PGE(2)-induced vasoconstriction is mediated by EP3 receptors on smooth muscle cells. Immunohistochemical staining of proximal ILAs confirmed the presence of EP3 receptor protein on these cells and the endothelium. Adding PGE(2) to normal isolated kidneys induced a biphasic flow response, i.e., an initial flow increase at PGE(2) concentrations <or=0.1 micromol/l followed by a flow decrease at 1 mumol/l PGE(2). Thus our results demonstrate that PGE(2) affects multiple segments of the preglomerular vascular tree in a different way. At the level of the proximal ILAs, PGE(2) had a direct vasoconstrictor action mediated by EP3 receptors.
- Subjects :
- Angiotensin II pharmacology
Animals
Arteries physiology
Arteries physiopathology
Bridged Bicyclo Compounds, Heterocyclic
Dinoprostone analogs & derivatives
Endothelium, Vascular drug effects
Endothelium, Vascular physiology
Endothelium, Vascular physiopathology
Fatty Acids, Unsaturated
Hydrazines pharmacology
Hydronephrosis physiopathology
In Vitro Techniques
Male
Muscle, Smooth, Vascular drug effects
Muscle, Smooth, Vascular physiology
Muscle, Smooth, Vascular physiopathology
Norepinephrine pharmacology
Perfusion
Rats
Rats, Sprague-Dawley
Receptors, Prostaglandin E analysis
Receptors, Prostaglandin E antagonists & inhibitors
Receptors, Prostaglandin E, EP1 Subtype
Receptors, Prostaglandin E, EP3 Subtype
Receptors, Thromboxane A2, Prostaglandin H2 antagonists & inhibitors
Renal Circulation drug effects
Vasoconstrictor Agents pharmacology
Arteries drug effects
Dinoprostone pharmacology
Kidney Cortex blood supply
Receptors, Prostaglandin E physiology
Vasoconstriction drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1931-857X
- Volume :
- 292
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- American journal of physiology. Renal physiology
- Publication Type :
- Academic Journal
- Accession number :
- 17148783
- Full Text :
- https://doi.org/10.1152/ajprenal.00351.2005